Verition Fund Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $700K | Buy |
39,307
+750
| +2% | +$13.4K | ﹤0.01% | 2064 |
|
|
2025
Q1 | $687K | Sell |
38,557
-10,909
| -22% | -$194K | ﹤0.01% | 1810 |
|
|
2024
Q4 | $1.47M | Buy |
+49,466
| New | +$1.47M | 0.01% | 1324 |
|
|
2024
Q3 | – | Sell |
-85,108
| Closed | -$1.46M | – | 2689 |
|
|
2024
Q2 | $1.46M | Buy |
85,108
+38,325
| +82% | +$657K | 0.01% | 1000 |
|
|
2024
Q1 | $731K | Buy |
+46,783
| New | +$731K | 0.01% | 1288 |
|
|
2023
Q3 | – | Sell |
-10,663
| Closed | -$443K | – | 2176 |
|
|
2023
Q2 | $443K | Buy |
10,663
+2,490
| +30% | +$103K | 0.01% | 1123 |
|
|
2023
Q1 | $492K | Buy |
+8,173
| New | +$492K | 0.01% | 1143 |
|
|
2022
Q1 | – | Sell |
-3,188
| Closed | -$239K | – | 2137 |
|
|
2021
Q4 | $239K | Buy |
+3,188
| New | +$239K | ﹤0.01% | 1482 |
|
|
2021
Q3 | – | Sell |
-1,626
| Closed | -$361K | – | 1929 |
|
|
2021
Q2 | $361K | Buy |
+1,626
| New | +$361K | ﹤0.01% | 1124 |
|
|
2020
Q3 | – | Sell |
-9,034
| Closed | -$536K | – | 1188 |
|
|
2020
Q2 | $536K | Buy |
+9,034
| New | +$536K | 0.02% | 517 |
|
|
2020
Q1 | – | Sell |
-3,619
| Closed | -$305K | – | 809 |
|
|
2019
Q4 | $305K | Sell |
3,619
-521
| -13% | -$43.9K | 0.01% | 703 |
|
|
2019
Q3 | $310K | Buy |
+4,140
| New | +$310K | 0.01% | 676 |
|
|
2019
Q2 | – | Sell |
-6,436
| Closed | -$310K | – | 1160 |
|
|
2019
Q1 | $310K | Buy |
+6,436
| New | +$310K | 0.01% | 754 |
|